Overview
Total raised
$10.4M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 15, 2026 | Longevity company HexemBio Unveils Three Generation Product Line, Backed by $15.5 Million in Total Funding | HexemBio Logo New investors join Draper Associates and Boost VC as the company moves its lead cell therapy toward human trials and develops its second-generation injectable SAN FRANCISCO, CA, UNITED STATES, September 15, 2026 /EINPresswire.... |
| Apr 7, 2026 | HexemBio Launches with $10.4M Seed Round to Advance Blood Stem Cell Rejuvenation Therapy | HexemBio Logo HexemBio emerges with a breakthrough blood stem cell rejuvenation technology led by Draper Associates and an advisory board that includes Co-Founder of Moderna SAN FRANCISCO, CA, UNITED STATES, April 7, 2026 /EINPresswire.com/... |
| Apr 7, 2026 | HexemBio Raises $10.4M in Seed Funding | HexemBio, a NYC-based biotechnology company developing blood stem cell rejuvenation therapies, raised $10.4M in Seed funding. The round was led by Draper Associates with participation from SOSV, Seraphim, and other investors. The company in... |
| heXem bio | “HexemBio” |
Reviews 0
FAQ about HexemBio
How much funding has HexemBio raised?
HexemBio has raised $10.4M in total across 1 funding round.
What has the press written about HexemBio?
Parsers VC has collected 5 articles mentioning HexemBio, among them “Longevity company HexemBio Unveils Three Generation Product Line, Backed by $15.5 Million in Total Funding” (Sep 15, 2026) and “HexemBio Launches with $10.4M Seed Round to Advance Blood Stem Cell Rejuvenation Therapy” (Apr 7, 2026).
Is HexemBio still active?
Yes, HexemBio is active; its latest activity on Parsers VC dates from Sep 22, 2026.